Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3
                    Genes That Are Both Downregulated in Expression in Breast and Prostate
                    Cancers by Yamamoto, Miyako et al.
Rare and Frequent Promoter Methylation, Respectively,
of TSHZ2 and 3 Genes That Are Both Downregulated in
Expression in Breast and Prostate Cancers
Miyako Yamamoto
1,2*, Emili Cid
2, Samuel Bru
2, Fumiichiro Yamamoto
1,2
1Burnham Institute for Medical Research (BIMR), La Jolla, California, United States of America, 2Institute of Predictive and Personalized Medicine of Cancer (IMPPC),
Badalona, Barcelona, Spain
Abstract
Background: Neoplastic cells harbor both hypomethylated and hypermethylated regions of DNA. Whereas hypomethyla-
tion is found mainly in repeat sequences, regional hypermethylation has been linked to the transcriptional silencing of
certain tumor suppressor genes. We attempted to search for candidate genes involved in breast/prostate carcinogenesis,
using the criteria that they should be expressed in primary cultures of normal breast/prostate epithelial cells but are
frequently downregulated in breast/prostate cancer cell lines and that their promoters are hypermethylated.
Methodology/Principal Findings: We identified several dozens of candidates among 194 homeobox and related genes
using Systematic Multiplex RT-PCR and among 23,000 known genes and 23,000 other expressed sequences in the human
genome by DNA microarray hybridization. An additional examination, by real-time qRT-PCR of clinical specimens of breast
cancer, further narrowed the list of the candidates. Among them, the most frequently downregulated genes in tumors were
NP_775756 and ZNF537, from the homeobox gene search and the genome-wide search, respectively. To our surprise, we
later discovered that these genes belong to the same gene family, the 3-member Teashirt family, bearing the new names of
TSHZ2 and TSHZ3. We subsequently determined the methylation status of their gene promoters. The TSHZ3 gene promoter
was found to be methylated in all the breast/prostate cancer cell lines and some of the breast cancer clinical specimens
analyzed. The TSHZ2 gene promoter, on the other hand, was unmethylated except for the MDA-MB-231 breast cancer cell
line. The TSHZ1 gene was always expressed, and its promoter was unmethylated in all cases.
Conclusions/Significance: TSHZ2 and TSHZ3 genes turned out to be the most interesting candidates for novel tumor
suppressor genes. Expression of both genes is downregulated. However, differential promoter methylation suggests the
existence of distinctive mechanisms of transcriptional inactivation for these genes.
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Introduction
Homeobox genes have a key role in the specification and
patterning of body parts during development [1,2,3,4,5,6,7]. These
genes contain a highly conserved 183-bp sequence (homeobox) and
encode proteins that specifically bind to DNA acting as transcrip-
tional modulators [8,9]. There areat least 178 homeobox sequences
in the human genome, 160 of which may be translated into
homeodomains within functional proteins [10]. Whereas regulated
cell growth and differentiation are the basis for development, cancer
results from uncontrolled growth of undifferentiated cells. Accord-
ingly, cancer maybe regarded as a dynamic developmental disorder
[11]. It is, therefore, not unreasonable to speculate that the
activation/inactivation of certain homeobox genes may contribute
to carcinogenesis. As a matter of fact, such examples have been
reported. Activation of homeobox genes was described in
hematopoietic cell lines either by incorporation of a viral regulatory
element in the vicinity of the homeobox gene or by chromosomal
rearrangement [12,13,14]. The oncogenic potential of certain
deregulated homeobox genes was also demonstrated by using in vitro
and in vivo transformation assays [15]. In contrast, other
homeoproteins with tumor suppressor activity have also been
reported [16,17,18,19,20,21,22].
We became interested in homeobox genes and its relationship
with cancer after analyzing the result of a previous work using
Methylation Sensitive-Amplified Fragment Length Polymorphism
(MS-AFLP) fingerprinting [23]. MS-AFLP is an efficient and
sensitive method that provides a rapid evaluation of DNA
methylation alterations at NotI landmarks. Using this method we
found that multiple homeobox and related genes exhibited
alterations in band intensity in cancer. The first hypermethylated
DNA fragment identified and characterized in most prostate and
some breast, but not in colon, cancers contained a sequence from
the HOX D Gene Complex, which is responsible for the
morphogenesis of the genitoexcretory apparatus [24,25,26].
Additional fingerprints yielded other altered bands belonging to
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17149
14the same homeobox gene family. Although the MS-AFLP method
provided an important clue to initiate the research on homeobox
genes in cancer based on the alterations in DNA methylation, not
all homeobox genes contain NotI sites.
Moreover, the relationship of DNA methylation status and
cancer has several major concerns that must be clarified. An issue
requiring resolution is if DNA methylation plays an active role in
carcinogenesis, rather than a passive role. On one hand, DNA
methylation alterations may occur progressively in cancer in a
directional manner by activating those genes with oncogenic
activity and/or inactivating those genes with tumor suppressor
activity and maintaining actively those changes in cancer cells. On
the other hand, DNA methylation changes may occur randomly,
even under normal conditions, and the cells that happen to possess
alterations which favor cell growth, may be selected during the
course of carcinogenesis. There is also the possibility that DNA
methylation is merely the result of carcinogenesis caused by an
altered expression of DNA-methyltransferase(s), without any
causal association with carcinogenesis. Other issues include
aging-dependent DNA methylation alterations and the uncoupling
of gene expression with the methylation state [27,28]. DNA
methylation patterns may change during aging, and this can
happen to cancer and normal cells complicating the comparison
among specimens belonging to different age groups. There are
also changes in DNA methylation that do not result in alterations
in gene expression, and therefore, their effects in carcinogenesis
are negligible. Because gene expression is functionally more
important than DNA methylation, we employed a more rigorous
and logical approach to identify homeobox genes involved in
carcinogenesis, by directly determining their expression.
Results
We constructed a SM RT-PCR system to analyze the
expression of homeobox genes. We designed two primers per
gene to amplify DNA fragments of different sizes in single exons
for the same gene group. For the 39 HOX genes in the HOX
Gene Complexes, which exhibit significantly high sequence
homology, primers were chosen for one conserved region
sequence and another unique region sequence in order to prevent
artificial recombinations among different gene transcripts [29].
For the other homeobox genes with lower sequence homology, we
used two unique primers. The list of the genes is shown in
Supplementary Table S1, together with the nucleotide sequences
of primers, their concentrations used, and the sizes of the amplified
DNA fragments. We were unable to design unique primer pairs to
discriminate the X-linked and Y-linked TGIF2L genes, and
therefore, both genes were amplified together. Additionally,
PAX1, PAX2, PAX5, PAX8, and LASS1 genes were incorporated
into the system because other members of their families possess a
homeodomain although they did not present it themselves.
Together with those 5 non-homeobox genes, the total SM RT-
PCR system covered 194 (195 if TGIF2LX and TGIF2LY were
counted separately) genes with some overlaps in 27 sets of
multiplex reactions. Using the homeobox SM RT-PCR system, we
examined the gene expression in normal and cancer cells of breast
and prostate. We placed an emphasis on the comparison between
primary culture of normal epithelial cells and established cancer
cell line cells, circumventing the heterogeneity and contamination
problems of tissues by the use of more homogeneous cells. Results
are shown in Figure 1. We identified 3-dozen homeobox genes
whose expression was altered in cancer cell line cells. They are
listed in Table 1. We were able to obtain, by SM RT-PCR, semi-
quantitative data on the expression of most of the homeobox genes
even though their mRNA levels were low in some cases. In
addition to genes with lost/diminished gene expression, genes with
enhanced gene expression were also identified.
We also carried out a genome-wide gene expression analysis in
normal and cancer cells of breast and prostate by DNA microarray
hybridization, using Illumina’s Sentrix Human-6 Expression
BeadChips. Data were used to sort out the genes by a function
of the frequency of the cell lines that exhibited an increased or
decreased gene expression. There were 73 genes and EST
sequences with enhanced gene expression in all the 5 breast and
3 prostate cancer cell lines when compared with the corresponding
normal epithelial cells. Among them, 37 showed a significant
increase in all cancer cell lines; these genes/EST sequences are
listed in Table 2. Because cancer cell line cells multiply much more
rapidly than normal cells, this list includes genes encoding for
centromere proteins, kinesin and kinetochore proteins, chromatin
proteins, cyclins and cell division cycle associated proteins, and
enzymes involved in DNA replication and nucleotide metabolism.
The list also includes v-myb myeloblastosis viral oncogene
homolog-like 2. Conversely, there were 67 genes and EST
sequences with diminished gene expression in all cancer cell lines
examined. Among them, 13, 9, and 10 showed a significant
decrease in 8 (all), 7, and 6 cancer cell lines, respectively. As
opposed to the upregulated genes, those downregulated genes
varied more widely, ranging from alpha-synuclein, a zinc finger
protein, a matrix metalloproteinase, and amylases, to dystrophin.
The list also includes genes for tumor protein p63, kallikrein-11,
and cytokeratin-14.
We performed real-time qRT-PCR using the same cDNA set.
Two dozens of promising candidate genes from the homeobox SM
RT-PCR screening were initially examined. These included
BAPX1 (NKX3-2), GBX2, HLXB9 (MNX1), LHX2 upregulated
genes and LASS3, NP_775756, CXorf43 (HDX), IRX1,
POU3F1, and RAX downregulated genes. As a control, we also
examined the expression of the DYM gene. This gene encodes
Dymeclin (Dyggve-Melchior-Clausen syndrome protein) [30] and
both SM RT-PCR and DNA microarray hybridization experi-
ments showed an abundant, ubiquitous expression in all the cells
and tissues examined [31]. Ct values were obtained for individual
reactions from the real-time qRT-PCR data. We also measured the
intensity of the SM RT-PCR bands using ImageQuant software
and calculated the log2 values. Similarly, we extracted the
fluorescence intensity of the corresponding genes from the DNA
microarray hybridization experiments and calculated the log2
values. We then plotted those values against the Ct values for
comparison. Representative results for BAPX1 (NKX3-2),
CXorf43 (HDX), HLXB9 (MNX1), IRX1, LASS3, and
NP_775756 are shown in Figure 2. The result for the DYM gene
is also shown on the top row. The differences in gene expression
observed by SM RT-PCR were confirmed by real-time qRT-PCR,
although some of them were not detected by DNA microarray
hybridization. Figure 2 also clearly demonstrates a higher degree
of linearity between the SM RT-PCR and real-time qRT-PCR
results than between the DNA microarray hybridization and real-
time qRT-PCR. This is reasonable because both SM RT-PCR and
real-time qRT-PCR are PCR-based techniques and the same pairs
of primers that were proven useful in the SM RT-PCR were used
in the real-time qRT-PCR experiments. As a next step, we
performed real-time qRT-PCR using cDNA prepared from clinical
specimens of breast cancer. Cancer cell lines provide a useful
starting point for the discovery and functional analysis of genes
involved in cancer. Alterations found in cancer cell lines, however,
may not necessarily be present in the original tumors. Those
changes may have been acquired during a long in vitro cultivation.
TSHZ2 and 3 Genes in Breast and Prostate Cancers
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also observed in clinical cancer specimens. We did this, using
cDNA prepared from 12 matched normal and tumor pairs of
breast tissues. Together with the two-dozen homeobox genes
including those ten described above, we also selected two-dozen
genes that exhibited frequent downregulation in the DNA
microarray hybridization experiments and determined their gene
expression in the clinical breast cancer specimens. The selected
genes included: ZNF537, AMY2A/2B (2 genes analyzed simul-
taneously), TP73L (TP63), CALML3, KRT14, PCSK5, CSTA,
CSPG2 (VCAN), DKFZP586H2123 (PAMR1) and FLRT2. The
DYM gene was used as a control to normalize the expression
levels. The differences between the normalized Ct values (minus
DYM Ct) of the matched normal and tumor pairs of breast tissues
were plotted. The differences between normal epithelial cells and
established cancer cell lines were also plotted. Several of the genes
exhibiting interesting gene expression patterns (MEOX1,
HOXA5, HOXA9, SNCA, VCAN, PAMR1, and MMP28 genes)
are shown in Figure 3.
Real-time qRT-PCR confirmed that all of the above-mentioned
gene expression differences in cancer cell lines were real. However,
only a subset of genes remained as candidates after performing
real-time qRT-PCR of breast cancer clinical specimens. The results
also showed that the NP_775756 and ZNF537 genes were the
most promising candidates among those examined in the
homeobox gene and other gene categories, respectively, because
their decreased expression in tumors was observed at the highest
frequency in breast cancer cases. When we searched for
information on those genes using the more recent version of the
Ensembl Human Genome Database, we were astounded to
discover that they were renamed as TSHZ2 and TSHZ3 and
categorized into the same 3-member gene family named Teashirt
(tsh). These genes encode for proteins with widely spaced zinc
finger motifs. The normal vs. cancer comparative expression levels
of these genes are also shown in Figure 3, together with the
expression level of the TSHZ1 gene.
While our project was underway, papers were published
reporting changes in DNA methylation of the HOX A Gene
Complex associated with breast cancer [32,33]. Novak et al. also
observed concomitant epigenetic silencing of the genes in the
HOX A Gene Complex. Because we only observed the
downregulation of HOXA9 and HOXA10 genes in this complex
by expression analysis of breast and prostate cancer cell lines, we
decided to examine, this time by real-time qRT-PCR, changes in
expression of several other HOXA and other additional
homeobox genes in clinical cases of breast cancer. The results
Figure 1. SM RT-PCR results of breast and prostate cells and tissues. The results of 27 sets of experiments are shown. cDNA sources are
abbreviated as follows: normal sample (NB) and primary tumor (TB) of breast tissue from an individual; normal sample (NP), and primary tumor tissues
(TP) of prostate from an individual; normal prostate tissue (NP) from a third individual; a hyperplastic prostate tissue (HyP) from a fourth individual;
primary cultures of normal mammary (MP) and prostate (PP) epithelial cells; and MCF7 (MCF), MDA-MB-468 (468), MDA-MB-231 (231), BT-20 (BT), T-
47D (T47), PC3 (PC), DU145 (DU), and LNCaP (LN) cancer cell lines. The genomic locations of the DNA fragments amplified from each individual gene
are also shown on the left side of gel pictures. The symbol M denotes DNA fragment size markers, and G heads the results of control genomic DNA.
Differential expression was observed with some homeobox genes.
doi:10.1371/journal.pone.0017149.g001
Table 1. Homeobox genes that exhibited gene expression alterations in breast and prostate cancer cell lines by SM RT-PCR.
Both in breast and
prostate cancer cells
UP
HLXB9 (MNX1) All 5 breast and 3 prostate cancer cell
lines
BAPX1 (NKX3-2), GBX2, LHX2 7 cancer cell lines
IPF1 6
PAX6 5
DOWN
LASS3, NP_775756 (TSHZ2) 8
CXorf43 (HDX), IRX1, POU3F1 7
HOP (HOPX) 6
C10orf48 (MKX), CRX, EVX2, MEOX1, PAX2, PAX8, PEPP2 (RHOXF2), VENTX2 (VENTX) 5
CDX1, HOXA10, IRX4, NANOG, PEPP1 (RHOXF1), PROX1, PRRX1 4
HOXA9, MEOX2 3
IRX2, LMX1A 2
Only in breast
DOWN
RAX 4 out of 5 cell lines
Only in prostate
DOWN
CUTL2 (CUX2), DLX5, EMX2, HOXD10, HOXD11, POU2F3 3 out of 3 cell lines
HOXD1, HOXD9 2
doi:10.1371/journal.pone.0017149.t001
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expression of many HOXA genes was lower in tumor tissues than
in the neighboring normal tissues. However, the expression of
those genes is not downregulated in a majority of breast/prostate
cancer cell line cells, compared to the expression levels of primary
culture of normal epithelial cells and/or normal tissues. In
addition to the HOXA genes, we also observed discrepancies
between cancer cell lines and clinical specimens in the expression
of several homeobox genes that were analyzed. Among the genes
found to be upregulated in cancer cell lines, GBX2 and IPF1 did
not exhibit such tendency among clinical breast cancer cases.
Among the downregulated genes in cancer cell lines, the
correlation was weak with POU3F1 and CXorf43 (HDX), and a
reverse tendency of upregulation was observed with CRX, HOP
Figure 2. Correlation between the band intensity observed from the SM RT-PCR or the fluorescence intensity from DNA microarray
hybridization and the Ct values obtained from the real-time qRT-PCR experiments. The log2 values of the band intensity (closed triangles)
or fluorescence intensity (open squares) were plotted along the Y-axis against the Ct values on the X-axis. The DYM gene was used as a control.
Negative and zero values obtained by microarray hybridization experiments were assigned the value of 0.1 for these graphs. The results for DYM were
enlarged and are shown of the right graph on the top row. A higher degree of linearity was observed between the results of SM RT-PCR and real-time
qRT-PCR than between the results of DNA microarray hybridization and real-time qRT-PCR.
doi:10.1371/journal.pone.0017149.g002
Table 2. Genes that exhibited gene expression alterations in breast and prostate cancer cell lines by DNA microarray hybridization.
UP
CNPM (C22orf18), CDCA3, RAD51AP1 (PIR51), EXO1, SPC24 (Spc24), NCAPH (BRRN1), MYBL2, E2F2, CDCA5, HELLS, TTK,
CDCA2, RRM2, SNG1 (SYNGR1), FLJ13909 (C16orf59), MCM10, ASF1B, CDCA2, POLE2, hmm18735 (ERCC6L), CANP
(FAM111B), ORC1L, dJ383J4.3 (CENPL), CDC25C, FLJ23311 (E2F8), PIF1, CDKN2C, C13orf3 (SKA3), TRIP (TRAIP), BCL2L12,
MGC2603 (C1orf135), KIFC1, FLJ13848 (NAA40), FLJ12973 (WDR76), RAD51, FLJ10520 (RFWD3), Hs.509236 (GNB2L1)
All the 5 breast and 3
prostate cancer cell lines
DOWN
ZF537 (TSHZ3), MMP28, AMY2A, DMD, TP73L (TP63), AMY2B, EDNRA, LOC163782 (KANK4), CALML3, SNCA, SERPINF1,
CAPN3, ALOX15B
All the 5 breast and 3
prostate cancer cell lines
DFZP586H2123 (PAMR1), DOC1 (FILIP1L), PTGS1, PCSK5, FLRT2, KRT14, CSTA, CSPG2 (VCAN), P2RY5 (LPAR6) 7 cancer cell lines
FJ23221 (C1orf54), TRIM22, DLL1, KIAA0450 (PLCH2), KCTD12, KLK11, DKK3, PTGS2, Hs.16515 (COBLL1), CCND2 6 cancer cell lines
doi:10.1371/journal.pone.0017149.t002
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different specimens, altered expression during the in vitro
cultivation, or else, may be responsible for the differences.
Although the causes remain to be determined, we decided to
focus our attention on TSHZ2 and TSHZ3, the Teashirt family of
homeobox genes that exhibited the same inclination towards a
diminished expression in both established cancer cell lines and
clinical specimens with the highest frequency of all candidates.
We examined the DNA methylation status of TSHZ genes in
their promoter regions in normal and cancer cells from breast and
prostate tissues. The sodium bisulfite modification method was
utilized followed by PCR. The nucleotide sequences of the
amplified DNA fragments were directly determined without
cloning. For the majority of samples that exhibited some
methylation, we also determined the nucleotide sequences of the
amplified fragments after cloning into a plasmid vector in order to
evaluate the degree of methylation more accurately. Ten
independent clones were sequenced for each sample, and the
frequency of methylation was calculated. Results are schematically
shown in Figure 4. Individual cytosine residues from CpG
dinucleotides in the amplified DNA fragments are represented
by circles (as determined by direct DNA sequencing without
cloning) or by squares (as determined by cloning). The percentages
of methylated cytosines are indicated in grey scale (open circle/
square ,10% methylation, closed circle/square .90% methyla-
tion). The promoter region of the TSHZ1 gene, which is expressed
in both normal and cancer cells/tissues of breast and prostate, was
found unmethylated irrespectively of the normal/cancer status
(top panel). The TSHZ2 gene promoter region was also
unmethylated in all the cells and tissues examined with the
exception of the MDA-MB-231 breast cancer cell line cells (middle
panel). The methylation status of the TSHZ3 gene promoter
depended on the pathological state of the cells (bottom panel). It
was unmethylated in normal epithelial cells, as well as normal
tissues, of breast and prostate, whereas in all the cancer cell lines
examined the corresponding region was partially or entirely
methylated. We also examined 7 additional breast tumor tissues,
and found that several had some degree of methylation at the
TSHZ3 gene promoter region analyzed.
Discussion
Cancer is the result of a series of genetic and epigenetic mishaps
subjected to natural selection. All cancers involve a disruption of
normal restraints in cell proliferation, differentiation, and survival.
Two major routes exist that contribute to uncontrolled cell
proliferation; activation of proto-oncogenes and inactivation of
tumor suppressor genes [34]. Structural changes in critical
Figure 3. Relative expression levels of the selected genes in
normal epithelial cells vs. cancer cell line cells and matched
normal vs. cancer breast tissues. The expression of two-dozen
candidate genes selected from the SM RT-PCR and DNA microarray
hybridization screenings was determined in clinical samples. Only the
representative results are shown. RNA from twelve matched pairs of
normal and tumor tissues of breast was analyzed, in addition to the
normal breast and prostate epithelial cells and 5 breast and 3 prostate
cancer cell lines. Real-time qRT-PCR was employed. The expression of
the DYM gene was used to normalize the expression data. The
differences between the normalized Ct values (minus DYM Ct) of cancer
cells/tissues and those of normal cell/tissues were calculated and
plotted. The black diamonds, open squares, and grey triangles
represent the results of clinical cases, breast cancer cell lines, and
prostate cancer cell lines, respectively. The dots above the y=0 line
indicate downregulation in tumor, whereas dots below indicate
upregulation.
doi:10.1371/journal.pone.0017149.g003
Table 3. Expression analysis of homeobox genes in clinical specimens of breast cancer by real-time qRT-PCR.
Gene Value Gene Value
Name .10 , ,1 21, ,0 ,21 Name .10 , ,1 21, ,0 ,21
HOXA5 11 1 0 0 HOXA3 10 2 0 0
HOXA7 10 2 0 0 HOXA9 10 2 0 0
MEOX1 10 2 0 0 HOXA10 7 3 2 0
HOXA11 6 4 0 1 PEPP1 9 1 1 1
PEPP2 6 3 1 2 IPF1 6 2 1 3
C10orf48 5 3 1 3 NP_116142 6 1 0 5
LASS3 4 3 2 3 NANOG 4 3 2 3
GBX2 5 1 3 3 POU3F1 5 1 2 4
CXorf43 2 4 2 4 CRX 5 0 3 4
BAPX1 2 3 1 6 LHX2 2 2 4 4
HOP 2 0 4 6 IRX4 1 1 3 7
HLXB9 1 0 1 7
The twelve matched normal and tumor tissue pairs of breast cancer were categorized by their subtractive values (normalized Ct values of cancer tissue – normalized Ct
values of the corresponding normal tissue). The positive and negative values represent downregulation and upregulation in cancer tissues, respectively.
doi:10.1371/journal.pone.0017149.t003
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inactivate their function. The activation may also occur through
an increased gene copy number and enhanced gene expression
whereas the inactivation may also occur by decreasing the copy
number and downregulation of gene expression. Therefore,
changes in copy number and expression have been used as
landmarks to identify dozens of cancer-related genes. In this work
we searched for genes that exhibit consistent differences in
expression between normal epithelial cells and established cancer
cell line cells. We analyzed breast and prostate cancers, which
progress from an early, sex hormone-dependent, organ-confined
disease to a highly invasive, hormone-independent, metastatic
disease that invades regional lymph nodes and distant organs, such
as the skeletal system. Although they are similar, breast and
Figure 4. DNA methylation status of TSHZ 1, 2, and 3 gene promoter regions in normal and cancer breast/prostate cells and tissues.
The DNA methylation states of individual cytosine residues from CpG dinucleotides in the amplified DNA fragments are represented schematically.
The degree of methylation is indicated by increasing darkness with open and closed symbols correspond to unmethylated and fully methylated
cytosines. The squares and circles indicate the results obtained by nucleotide sequencing with and without cloning, respectively.
doi:10.1371/journal.pone.0017149.g004
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aimed to identify genes that exhibited altered expression in breast,
prostate, or both cancers. We also decided to use normal and
cancer cells rather than tissues to circumvent the heterogeneity
and contamination problems of tissues. Additionally, we took two
different approaches: SM RT-PCR and DNA microarray
hybridization. The former was targeted to homeobox genes while
the latter was used for the genome-wide analysis.
The search resulted in the identification of dozens of genes that
exhibited altered gene expression in breast/prostate cancer. Many
of the HOXA genes were downregulated in clinical specimens of
breast cancer. However, they were excluded from the candidate
list because several breast/prostate cancer cell line cells did not
satisfy the criteria when compared with the expression levels of
primary cultures of normal epithelial cells and normal tissues. This
implicates that different selection criteria would have resulted in
different results. Amazingly, after real-time qRT-PCR screening
using clinical specimens of breast cancer the top candidates from
the two separate approaches turned out to belong to the same
Teashirt family of genes. When we constructed the SM RT-PCR
system of homeobox genes, ZNF537 (TSHZ3) was not annotated.
The NP_775756 (TSHZ2) gene was not listed among the top
candidates from the DNA microarray hybridization approach
because its expression was lower in the primary cultures of normal
epithelial cells and several dozens of better candidates were
identified. In fact we might have missed those interesting
homeobox genes if we had not performed both the SM RT-
PCR and DNA microarray hybridization experiments. Because
the TSHZ2 gene was selected from homeobox genes and the
TSHZ3 gene was selected from the sum of 46,000 genes/ESTs
and as there are only 3 members in the Teashirt gene family, we
have concluded that our finding is not a mere coincidence of one
in 3 millions (1/19461/46,00063=1/2,974,666). A decrease in
expression of the TSHZ2 and TSHZ3 genes was observed in
100% of the breast cancer clinical cases examined. The
downregulation of these genes may also be observed in several
other types of cancers, very probably including prostate cancer. In
comparison, the TP53 gene (p53) is altered in 40% of breast
carcinomas cases (Catalogue of Somatic Mutations in Cancer
(COSMIC) database: http://www.sanger.ac.uk/genetics/CGP/
cosmic/), and although germline alterations in the BRCA1 and
BRCA2 genes are involved in many cases of hereditary breast and
ovarian cancers, the hereditary form of these diseases account for
only 5 to 10% of the total cases.
Because the downregulation of mRNA stationary levels is likely
caused by decreased transcriptional activity, it is necessary to
examine the alterations in chromatin structure surrounding the
TSHZ2 and TSHZ3 gene promoters. As an initial step, we
examinedchangesintheirDNAmethylation.AllthreeTSHZgenes
contain regions highly rich in CpG dinucleotides around exon 1,
suggesting that those regions represent CpG islands. Therefore, we
anticipated that the TSHZ2 and TSHZ3 promoters might be
hypermethylated in the non-expressor cancer cell line cells whereas
in the expressors they would be hypomethylated, as it has been
demonstrated with other tumor suppressor genes [27,28]. We also
expected no difference in the methylation status of the TSHZ1 gene
in the TSHZ2 and TSHZ3 expressor and non-expressor cells/
tissues. TheDNAmethylation analyses showedthat thepromoterof
the TSHZ1 gene is, as we expected, unmethylated in all the
examined cells and tissues. Furthermore, the methylation status of
the TSHZ3 gene promoter correlated well with its gene expression
(unmethylated in expressor cells/tissues and methylated in non-
expressor cells/tissues) as we also anticipated. On the contrary, the
results of TSHZ2gene promoterwere somewhatunexpected. It was
found unmethylated except in the MDA-MB-231 cells, suggesting
the presence of other gene silencing mechanisms than DNA
methylation. One possible mechanism may be a diminished or
abolished expression of an upstream transcription factor(s) respon-
sible for the TSHZ2 gene expression. In Drosophila, the Teashirt (tsh)
gene is required for the development of embryonic trunk segments
[35]. Additionally, tsh is also necessary for midgut morphogenesis,
the patterning of adult eyes, and the development of the proximal
portion of adult appendages [36,37,38]. In mice, TSHZ1 regulates
posterior identity in brain and cranial neural crest cells [39], and is
required for axial skeleton, soft palate and middle ear development
[40]. The three mouse Teashirt genes could rescue both the
homeotic and the segment polarity phenotypes of a tsh null fruitfly
mutant [41]. The mammalian genes are also expressed in domains
both dorsoventrally and rostrocaudally restricted, with major
changes in expression levels coinciding with compartment bound-
aries [42]. Mice that are null mutant for TSHZ3 exhibit congenital
pelvi-ureteric junction obstruction with defective smooth muscle
differentiation and absent peristalsis in the proximal ureter,
suggesting a role in organ development [43,44]. Recent reports
have correlated the TSHZ genes to human diseases: reduced
expression of TSHZ3 protein to Alzheimer disease [45] and
deletion of the TSHZ1 gene, which is located at the 18q22.3 critical
region, to 18q deletion syndrome [46]. Patients with the latter
syndrome display a multiple-anomaly disorder associated with
mental retardation, white matter anomalies in the brain, growth
hormone deficiency, congenital aural atresia, orofacial cleft, and
palate abnormalities.
Apparently Teashirt genes/proteins have never been associated
to carcinogenesis except that TSHZ1 protein was found reactive
with an autologous IgG from patients with colon cancer (NY-CO-
33 colon cancer antigen) [47]. Therefore, it will be interesting and
necessary to determine the role and significance of THSZ2 and
TSHZ3 transcriptional inactivation in cancer. We hypothesize
that their gene silencing may play an active role in carcinogenesis.
There already exists some evidence to support this. The Teashirt
proteins were found in the Wnt signaling pathway in Drosophila
and, in humans, as part of a gene-silencing complex in neuronal
cells. In Drosophila, the Wnt protein Wingless acts to stabilize
Armadillo inside cells where it binds to at least two DNA-binding
factors, which regulate specific target genes. One of the Armadillo-
binding proteins is the Teashirt protein [48]. Upon an
extracellular signal (e.g. Wg/Wnt), Arm/b-catenin seems to
recruit the Teashirt protein and stimulates the entry into the
nucleus, where the bipartite complex can collaborate with general
DNA-binding factors to regulate specific target genes of the
pathway. In humans the activation of gene transcription by b-
catenin plays a critical part in carcinogenesis, and actually, three
regulatory genes in the Wnt signaling pathway are found to be
mutated in primary cancers [49]. The study on human neuronal
cells revealed another role of Teashirt proteins as transcriptional
repressors [45]. The FE65 adaptor protein, which can bind to the
amyloid protein precursor, simultaneously recruits SET, a
component of the acetyl transferase inhibitor, and the Teashirt
protein, which in turn recruits histone deacetylases, to produce a
gene-silencing complex [45]. Interestingly, decreasing expression
of Teashirt (due to genetic or other causes) and increasing
expression of caspase-4, a target of the silencing complex, were
correlated with progressive cognitive decline in AD patients.
We do not know if the downregulation of TSHZ2 and TSHZ3
genes is the result of shutting down gene expression when normal
expressor cells dedifferentiate and become malignant or if it is the
result of transcriptional activation when the non-expressor stem
cells, which develop into cancer cells, differentiate into epithelial
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allows discrimination of normal, differentiated epithelial cells from
undifferentiated (dedifferentiated) cancer cells, and therefore, it is a
potentially useful diagnostic cancer marker. We do not know
whether Teashirt proteins work as activator or suppressor of
transcription in epithelial cells, either. However, it is likely that
decreased TSHZ gene expression not only results in the decline of
the TSHZ proteins but it also elicits multi-faceted changes in the
expression of downstream genes. The CASP4 gene may not be a
target gene in the epithelial cell system. Rather, one or several of
such genes that are shown to be either upregulated or downreg-
ulated in cancer cells in Table 2 may turn out to be the target genes.
Secondary changes in the protein profile may provide useful targets
for pharmacologically active compounds. In addition to elucidate
the downstream genes, there are many additional questions
regarding the functions of the Teashirt proteins in carcinogenesis.
We hope to provide definitive answers in future studies.
Materials and Methods
Systematic Multiplex RT-PCR (SM RT-PCR)
Tomeasuretheexpressionof194homeoboxandrelatedgeneswe
used the following total RNA samples: a normal and a primary
breast tumor tissue from a patient with invasive ductal carcinoma, a
normal and a primary carcinoma tissue of prostate from a patient
with prostate cancer, another normal prostate tissue, and a
hyperplastic prostate tissue, primary cultures of normal mammary
and prostate epithelial cells,and 5 mammary (BT-20,MCF7, MDA-
MB-231, MDA-MB-468, and T-47D) and 3 prostate (DU145,
LNCaP, and PC3) cancer cell lines. The normal and cancerous
human tissues were obtained from the Cooperative Human Tissue
Network (CHTN). The primary cultures of human epithelial cells
and the established cancer cell line cells were purchased from
Cambrex and American Type Culture Collection (ATCC),
respectively. We prepared cDNA by reverse-transcription using
oligo dT primers and the Advantage RT-for-PCR Kit (BD
Biosciences-Clontech). We followed the SM RT-PCR experimental
protocols described previously [29,50,51,52]. Complementary DNA
samples were used as templates to examine gene expression. Small
aliquots of the SM RT-PCR reaction products were loaded onto 8%
polyacrylamide gels and electrophoresed. The gels were stained with
ethidium bromide and TIFF-formatted pictures were taken.
DNA microarray hybridization
In order to determine the genome-wide gene expression, the
same cDNA preparations that were used for SM RT-PCR were
also employed in microarray hybridization experiments. The
samples analyzed were a normal breast tissue, a normal prostate
tissue, primary cultures of normal mammary and prostate
epithelial cells, and 5 mammary and 3 prostate cancer cell lines.
Illumina’s Sentrix Human-6 Expression BeadChips, which
contained probes from the entire 23,000 RefSeq collection and
an additional 23,000 other expressed sequences, were used. We
followed Illumina’s protocol to prepare biotinylated cRNA and we
hybridized with the BeadChips. Fluorescence intensity was
measured with Illumina’s BeadStation 500. Raw data were
generated and then normalized using the Beadscan 3.0 software.
Real-time qRT-PCR
To measure the expression of selected genes two sets of cDNA
were analyzed: the same set of cDNA from the cells and tissues that
were used during the DNA microarray hybridization experiments
and another set from 12 matched pairs of normal and tumor breast
tissues. The reagent was the Power SYBR Green PCR Master Mix
(Applied Biosystems) and the primer pairs were the same used in the
SM RT-PCR experiments. The PCR products yields were
monitored using the Mx3000p system (Stratagene) under default
conditions, with the exception of an increase in the annealing
temperature to 60uC instead of 55uC. Data were analyzed using the
MxPro software. Cycle threshold (Ct) values were obtained for each
individual reaction, and the Ct of the ubiquitously expressed DYM
gene was subtracted to obtain the normalized values.
DNA methylation analysis
DNA methylation status was determined for TSHZ1, 2, and 3
gene promoters, using genomic DNA from the same cells/tissues
analyzed for gene expression. We employed the sodium bisulfite
modification method followed by PCR and DNA sequencing as
previously described [53]. Briefly, DNA sequences surrounding the
transcription initiation sites of the TSHZ genes were retrieved from
the Ensembl Human Genome Database, and the CpG-rich regions
were identified. Genomic DNA was treated with sodium bisulfite
underthe conditionsthatallowedtheconversionofcytosine,butnot
5-methylcytosine, to uracil [54]. The modified DNA was treated
with sodium hydroxide followed by ethanol precipitation. DNA
fragments containing multiple CpG dinucleotides from the TSHZ
gene promoters were PCR-amplified and directly sequenced, using
primers corresponding to the bisulfite-converted sequences without
CpG dinucleotides. The nucleotide sequences of the primers used
are:TSHZ1-F (GGGAGGAAAAGGATAGTTTGTAT), TSHZ1-
R (CAACTTTCTCTCCCCCTCTCTCCT), TSHZ2-F (GGAG-
GAGTTTGTTAATGTTTAG),TSHZ2-R (AAAATCTAAAAT-
TCACTCACTCACAC),TSHZ3-F (GGGGGATTGTTTGGT-
GTT), and TSHZ3-R (CATCTAACAATACCCAAACCCTAT).
The locations in the human genome of the amplified DNA
fragments are: TSHZ1 (Chr:18, 72923259-72923378), TSHZ2
(Chr:20, 51588877-51589110), and TSHZ3 (Chr:19, 31839537-
31839698) (Ensembl release 59-Aug 2010). The DNA methylation
status at individual CpG sites was manually annotated. For several
specimens, the PCR reaction products were also cloned into the
pCR2.1 plasmid vector, using the T-A cloning method. After DNA
transformation of competent Escherichia coli bacteria, plasmid DNA
was prepared from independent clones, and ten clones were
sequenced in order to obtain more accurate estimates of
methylation frequency.
Supporting Information
Table S1 The list of the genes analyzed by SM RT-PCR is
shown, together with the nucleotide sequences of primers, their
concentrations used, and the sizes of the amplified DNA
fragments.
(PDF)
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